<p>It is well-known that <i>Enterococcus</i> species produce bacteriocins that have antibacterial activity. However, a comprehensive analysis of the bacteriocin distribution among <i>Enterococcus</i> strains has not been conducted. In this study, we identified the bacteriocin genes from 80 <i>Enterococcus faecalis</i> and 38 <i>Enterococcus faecium</i> strains and investigated their antibacterial activity. In the 80 <i>E. faecalis</i> strains, the cytolysin gene (61.3%), enterolysin A gene (27.5%) and BacL<sub>1</sub> gene (45.0%) were identified. In the 38 <i>E. faecium</i> strains, the enterocin A gene (97.4%), enterocin B gene (2.6%), enterocin NKR-5-3B gene (21.0%), bacteriocin T8 gene (36.8%) and BacAS9 gene (23.7%) were identified. The antibacterial activity of all strains was tested against <i>E. faecalis</i> and <i>E. faecium</i>. The strains positive for the cytolysin, enterolysin A, BacL<sub>1</sub>, bacteriocin T8 or BacAS9 genes presented variable antibacterial activity. Several bacteriocin-positive strains showed antibacterial activity against other enterococcal species, but not against <i>Staphylococcus</i> or <i>Escherichia coli</i>. In addition, the enterolysin A-positive strain showed antibacterial activity against vancomycin-resistant <i>E. faecium</i>, and the bacteriocin T8- or BacAS9-positive strains showed activity against vancomycin-resistant <i>E. faecalis</i> and <i>E. faecium</i>. Our findings suggest that <i>E. faecium</i> and <i>E. faecalis</i> strains that carry different bacteriocin genes may affect the composition of the surrounding bacterial community.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Comprehensive analysis of bacteriocins produced by clinical enterococcal isolates and their antibacterial activity against Enterococci including VRE

  • Ayumi Fujii,
  • Miki Kawada-Matsuo,
  • Mi Nguyen-Tra Le,
  • Yujin Suzuki,
  • Saki Nishihama,
  • Hideki Shiba,
  • Tomonao Aikawa,
  • Hitoshi Komatsuzawa

摘要

It is well-known that Enterococcus species produce bacteriocins that have antibacterial activity. However, a comprehensive analysis of the bacteriocin distribution among Enterococcus strains has not been conducted. In this study, we identified the bacteriocin genes from 80 Enterococcus faecalis and 38 Enterococcus faecium strains and investigated their antibacterial activity. In the 80 E. faecalis strains, the cytolysin gene (61.3%), enterolysin A gene (27.5%) and BacL1 gene (45.0%) were identified. In the 38 E. faecium strains, the enterocin A gene (97.4%), enterocin B gene (2.6%), enterocin NKR-5-3B gene (21.0%), bacteriocin T8 gene (36.8%) and BacAS9 gene (23.7%) were identified. The antibacterial activity of all strains was tested against E. faecalis and E. faecium. The strains positive for the cytolysin, enterolysin A, BacL1, bacteriocin T8 or BacAS9 genes presented variable antibacterial activity. Several bacteriocin-positive strains showed antibacterial activity against other enterococcal species, but not against Staphylococcus or Escherichia coli. In addition, the enterolysin A-positive strain showed antibacterial activity against vancomycin-resistant E. faecium, and the bacteriocin T8- or BacAS9-positive strains showed activity against vancomycin-resistant E. faecalis and E. faecium. Our findings suggest that E. faecium and E. faecalis strains that carry different bacteriocin genes may affect the composition of the surrounding bacterial community.